Research Papers are in chronological order below. The (*) refers to the corresponding author.
Chauhan SC, Ebeling MC, Maher DM, Koch MD, Watanabe A, Aburatani H, Lio Y, Jaggi M. MUC13 mucin augments pancreatic tumorigenesis. Mol Cancer Ther. 2011 Oct 25. [Epub ahead of print] PubMed PMID: 22027689.
Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 2011 Sep 18. [Epub ahead of print] PubMed PMID: 21959306.
Yallapu MM, Dobberpuhl MR, Maher DM, Jaggi M, Chauhan SC. Design of Curcumin loaded Cellulose Nanoparticles for Prostate Cancer. Curr Drug Metab. 2011 Sep 5. [Epub ahead of print] PubMed PMID: 21892919.
Sundram V, Chauhan SC, Jaggi M. Emerging roles of protein kinase D1 in cancer. Mol Cancer Res. 2011 Aug;9(8):985-96. Epub 2011 Jun 16. PubMed PMID: 21680539.
Maher DM, Gupta BK, Nagata S, Jaggi M, Chauhan SC. Mucin 13: structure, function, and potential roles in cancer pathogenesis. Mol Cancer Res. 2011 May;9(5):531-7. Epub 2011 Mar 30. Review. PubMed PMID: 21450906.
Yallapu MM, Jaggi M, Chauhan SC. Design and engineering of nanogels for cancer treatment. Drug Discov Today. 2011 May;16(9-10):457-63. Epub 2011 Mar 23. Review. PubMed PMID: 21414419; PubMed Central PMCID: PMC3095726.
Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials. 2011 Mar;32(7):1890-905. Epub 2010 Dec 16. PubMed PMID: 21167595; PubMed Central PMCID: PMC3021632.
Maher DM, Bell MC, O'Donnell EA, Gupta BK, Jaggi M, Chauhan SC. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7. Mol Carcinog. 2011 Jan;50(1):47-57. PubMed PMID: 21061268.
Yallapu MM, Ebeling MC, Chauhan N, Jaggi M, Chauhan SC. Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. Int J Nanomedicine. 2011;6:2779-90. Epub 2011 Nov 8. PubMed PMID: 22128249.
Yallapu MM, Jaggi M, Chauhan SC. Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromol Biosci. 2010 Oct 8;10(10):1141-51. PubMed PMID: 20572274.
Yallapu MM, Jaggi M, Chauhan SC. Scope of nanotechnology in ovarian cancer therapeutics. J Ovarian Res. 2010 Aug 6;3:19. PubMed PMID: 20691083; PubMed Central PMCID: PMC2924337.
Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M, Chauhan SC. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res. 2010 Apr 29;3:11. PubMed PMID: 20429876; PubMed Central PMCID: PMC2880315.
Chauhan SC., Kumar D. and Jaggi M. Mucins in ovarian cancer diagnosis and therapy. Journal of Ovarian Research 2009 Dec 24;2(1):21)
Chauhan SC., Vannatta K., Ebeling MC., Vinayek N., Watanabe A., Pandey KK., Maher D., Bell MC., Koch MD., Aburatani H., Lio Y. and Jaggi M. Expression and in vitro functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Research 2009;69(3) 765-774. PMID: 19176398.
Jaggi M#. , Du C #., Zhang C. and Balaji KC. Protein kinase D1 (PKD1) mediated phosphorylation and subcellular localization of β-catenin. Cancer Research 2009;69(3):1117-1124 (# equal contribution). PMID: 19141652.
Jaggi M*, Chauhan SC., Du C. and Balaji KC. Bryostatin modulates β-catenin subcellular localization and transcription activity through protein kinase D1 activation. Molecular Cancer Therapeutics 2008;7(9):2703-12 (Cover illustration). PMID: 18765827.
Mak P., Jaggi M., Viqar S., Chauhan SC., Hassan S., Biswas H. and Balaji K.C. Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells. Biochemical and Biophysical Research Communications 2008 Sep 373:618-23. PMID: 18602367.
Jaggi BK., Chauhan SC. and Jaggi M*. Effect of curcumin on signaling pathways in cancer. Proceedings of South Dakota Academy of Science (PSDAS) 2007; 86:283-293.
Jaggi M*., Du C., Zhang W. and Balaji KC. Protein Kinase D1: A Protein of Emerging Translational Interest. Front Biosci. 2007 May 1;12: 3757-67. PMID: 17485336.
Chauhan SC., Vinayek N., Dunham K., Lio Y., Koch MD. and Jaggi M. Analysis for MUC1, MUC16 and TAG-72 expression in ovarian cancer: Antigens of multi-targeted antibody guided therapy Journal of Histochemistry and Cytochemistry, 2007 Aug;55(8):867-75. PMID: 17478446.
Smith DJ., Jaggi M., Zhang W., Galich AN., Sterrett SP., Smith LM. and Balaji KC., Methallothioneins and Resistance to Cisplatin and Radiation in Prostate Cancer. Urology. 2006 Jun;67 (6):1341-7. PMID: 16765200.
Jaggi M*., Nazemi T., Baker JJ., Galich AN., Smith LM. and Balaji KC. N-cadherin Switching Occurs in High Gleason Grade Prostate Cancer. Prostate, 2006; 66(2): 193-199. PMID: 16173043.
Jaggi M*., Johansson SL., Smith LM., Baker JJ., Galich AN. and Balaji KC. Aberrant Expression of E-Cadherin and Beta-Catenin in Human Prostate Cancer. Urological Oncology, 2005, 23(6): 402-406. PMID: 16173043.
Lewis T., Milam T., Rao P., Jaggi M, Smith D., Hemstreet G. and Balaji KC. Tissue Transglutaminase Interacts with AKAP 13 in Prostate Cancer. Urological Oncology, 2005, 23(6): 407-412. PMID: 16301118.
Jaggi M., Rao PS., Smith DJ., Wheelock MJ.,Johnson KR., Hemstreet GP. and Balaji KC. E-cadherin Phosphorylation by PKD1/PKC mu is Associated with Altered Cellular Aggregation and Motility in Prostate Cancer. Cancer Research, 2005 65(2): 483-492. PMID: 15695390.
Rao PS., Jaggi M., Smith DJ., Hemstreet GP. and Balaji KC. Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer. Biochem Biophys Res Commun. 2003, 310(3): 1032-1038. PMID: 14550308.
Jaggi M., Rao PS., Smith DJ., Hemstreet GP. and Balaji KC. Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochemical and Biophysical Research Communications, 2003; 307(2): 254-260. PMID: 12859948.
Jaggi M. Wheelock MJ. and Johnson KR. Differential displacement of classical cadherins by VE cadherin. Cell Communication and Adhesion, 2002, 9(2): 103-115. PMID: 12487411.
|